SEC Comment Letter for Jaguar Health, Inc. (JAGX) (CIK 0001585608) (JAGX) — May 17, 2019
Jaguar Health, Inc. (JAGX) (CIK 0001585608)
Date: May 17, 2019 · CIK: 0001585608 · Accession: 0000000000-19-008676
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-231399
Letter
May 17, 2019 Lisa A. Conte Chief Executive Officer and President Jaguar Health, Inc. 201 Mission Street, Suite 2375 San Francisco, CA 94105 Re:Jaguar Health, Inc. Registration Statement of Form S-1 Filed May 10, 2019 File No. 333-231399 Dear Ms. Conte: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeffrey Gabor at 202-551-2544 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Michael Lee, Esq.
Show Raw Text
May 17, 2019
Lisa A. Conte
Chief Executive Officer and President
Jaguar Health, Inc.
201 Mission Street, Suite 2375
San Francisco, CA 94105
Re:Jaguar Health, Inc.
Registration Statement of Form S-1
Filed May 10, 2019
File No. 333-231399
Dear Ms. Conte:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jeffrey Gabor at 202-551-2544 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Michael Lee, Esq.